index - CRCL-Métabolisme du gliolastome et hétérogénéité tumorale

Paul Huchedé, Swann Meyer, Clément Berthelot, Maud Hamadou, Adrien Bertrand-Chapel, et al.. BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas. 2023. ⟨hal-04295430⟩
Arthur Bassot, Helena Dragic, Sarah Al Haddad, Laurine Moindrot, Soline Odouard, et al.. Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma. Cell Death and Disease, 2023, 14, ⟨10.1038/s41419-023-06117-z⟩. ⟨hal-04231610⟩
Linus Kruk, Attila Braun, Erika Cosset, Thomas Gudermann, Elmina Mammadova-Bach. Galectin functions in cancer-associated inflammation and thrombosis. Frontiers in Cardiovascular Medicine, 2023, 10, ⟨10.3389/fcvm.2023.1052959⟩. ⟨hal-04021160⟩
Helena Dragic, Cedric Chaveroux, Erika Cosset, Serge N Manie. Modelling cancer metabolism in vitro : current improvements and future challenges. FEBS Journal, 2022, ⟨10.1111/febs.16704⟩. ⟨hal-04132220⟩
Halah Kutaish, Laura Bengtsson, Philippe Matthias Tscholl, Antoine Marteyn, Vincent Braunersreuther, et al.. Hyaline Cartilage Microtissues Engineered from Adult Dedifferentiated Chondrocytes: Safety and Role of WNT Signaling. Stem Cells Translational Medicine, 2022, 11 (12), pp.1219-1231. ⟨10.1093/stcltm/szac074⟩. ⟨hal-04021164⟩
Erika Cosset, Sten Ilmjärv, Valérie Dutoit, Kathryn Elliott, Tami von Schalscha, et al.. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. Cancer Cell, 2017, 32, pp.856 - 868.e5. ⟨10.1016/j.ccell.2017.10.016⟩. ⟨hal-04021422⟩

Derniers manuscrits de l'équipe

Chiffres clés